Literature DB >> 4630453

The lysis of paroxysmal nocturnal haemoglobinuria red cells by serum and cobra factor.

T Kabakçi, W F Rosse, G L Logue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4630453     DOI： 10.1111/j.1365-2141.1972.tb03484.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.

Authors:  A K Cheung; C J Parker; L Wilcox
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.

Authors:  W F Rosse; G L Logue; J Adams; J H Crookston
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

3.  Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.

Authors:  R H Dixon; W F Rosse
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

4.  Characterization of alternative pathway inhibition by a serum derived, low molecular weight complement inhibitor.

Authors:  P J Baker; C J Parker; S G Osofsky
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

5.  Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.

Authors:  C J Parker; T Wiedmer; P J Sims; W F Rosse
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

6.  Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.

Authors:  G L Logue; W F Rosse; J P Adams
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

7.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

8.  Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.

Authors:  M J Telen; S E Hall; A M Green; J J Moulds; W F Rosse
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.